A block-randomized, double-blind, placebo-controlled, single-dose escalating, phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of YHB1411-2 in healthy male volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2016
At a glance
- Drugs YHB 1411-2 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Yuhan
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Sep 2013 Planned End Date changed from 1 May 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 31 Jul 2013 Planned number of patients changed from 44 to 49 as reported by Clinical Research Information Service (CriS) - Republic of Korea.